Melanoma of unknown primary: favorable survival persists in the immunotherapy era

Int J Dermatol. 2023 Apr;62(4):e236-e238. doi: 10.1111/ijd.16419. Epub 2022 Aug 28.

Authors

Satish Maharaj¹, Nikita Jain², Anas Al Bawaliz², Donald Miller², Jason Chesney²

Affiliations

¹ Hematology & Oncology, Texas Tech University, El Paso, TX, USA.
² Hematology & Oncology, University of Louisville, Louisville, KY, USA.

PMID: 36030543
DOI: 10.1111/ijd.16419

No abstract available

Publication types

Letter

MeSH terms

Humans
Immunotherapy
Melanoma* / therapy
Neoplasms, Unknown Primary* / therapy